new canadian guidelines have been released on when to prescribe menopausal hormone therapy — and when it might heighten health risks,
according to ctv news
.
menopausal hormone therapy (mht), according to the new guidelines, is the most effective treatment to relieve menopause symptoms, especially when they are severe. long-term data suggests that mht should not increase the risk of cardiovascular disease if it isn’t prescribed for women who are already at an increased risk of heart disease and isn’t prescribed for an extended period.
here’s the catch. menopause officially begins 12 months after a woman has had her last period. menopause symptoms, like hot flashes, night sweats, insomnia, mood swings, vaginal dryness and discomfort during intercourse, can last for many years for some women, or intensify at different points.
this change of life for women can be complicated. symptoms can also start in perimenopause, typically when women are in their 40s, when menstrual cycle length and flow can be irregular and unpredictable. and the hormones necessary for reproduction, estrogen and progesterone, fluctuate, causing confusing and uncomfortable symptoms, dr. jerilynn prior, a professor of endocrinology in the department of medicine at the university of british columbia and the scientific director at the centre for menstrual cycle and ovulation research,
told healthing early this year
.